MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-09-0016842
Nucleus Formulation Private Limited - pharma in Chhatral, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.79 Cr
▲ 14% YoY
Net profit · FY 2025
₹14.86 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹56.53 Lakh
EBITDA margin 9.8%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Open charges
₹2.57 Cr
Satisfied ₹5.83 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
13
Provident fund records
About Nucleus Formulation Private Limited
Data last updated:
Nucleus Formulation Private Limited is a private limited company based in Chhatral, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 July 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2009PTC057517. Its GSTIN is 24AADCN0507H1ZY (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Jitendra Lavjibhai Patel and Dipesh Jyotindrakumar Thakar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 3484 Ph – 4 GIDC Chhatral Tal Kalol, Gujarat, India – 382729.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.79 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹14.86 Lakh (net margin 2.6%) and EBITDA of ₹56.53 Lakh (EBITDA margin 9.8%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 7% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nucleus Formulation. As per MCA filings, the company has open charges of ₹2.57 Cr and satisfied charges of ₹5.83 Cr on record.
Nucleus Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-09-0016842). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nucleusformulation.com.
Company details
CIN U24239GJ2009PTC057517
Registration Number 057517
Incorporation Date 13 July 2009
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-09-0016842
Recognitions & Rankings of Nucleus Formulation
Contact details
Nucleus Formulation Private Limited's registered office is in Chhatral, Gujarat. Its website is nucleusformulation.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 3484 Ph – 4 GIDC Chhatral Tal Kalol, Gujarat, India – 382729
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nucleus Formulation Private Limited, buy the company report.
Comprehensive company report
Nucleus Formulation Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nucleus Formulation operates one associated brand: Nucleus Formulation. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical formulations for therapeutic needs and exports worldwide. | nucleusformulation.com |
Business activity
The main business activity of Nucleus Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nucleus Formulation Private Limited, buy the company report.
Financials of Nucleus Formulation Private Limited
FY 2025 filings availableNucleus Formulation Private Limited reported revenue of ₹5.79 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹5.79 Cr ▲ 14%
Net profit · FY 2025
₹14.86 Lakh margin 2.6%
EBITDA · FY 2025
₹56.53 Lakh margin 9.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▼ 14%
5 years · compounded
▼ 7%
EBITDA CAGR growth
3 years · compounded
▼ 20%
5 years · compounded
▼ 3%
Revenue rose 14% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹56.53 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.8% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nucleus Formulation Private Limited, buy the company report.
Board of directors of Nucleus Formulation Private Limited
Nucleus Formulation has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Lavjibhai Patel | Director | 13 Jul 2009 | 17 Years 3 Months | Current |
| Dipesh Jyotindrakumar Thakar Also directs: Dipjyot Global Trade Private Limited | Director | 13 Jul 2009 | 17 Years 3 Months | Current |
Peer comparison
Nucleus Formulation Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aaryveda Global Healthcare (I) Private Limited | ₹5.81 Cr (FY 2024) | Pune, Maharashtra, India | ||||
| Nucleus Formulation Private Limitedthis company | ₹5.79 Cr (FY 2025) | ₹14.86 Lakh | 2.6% | 14.0% | 13 | Chhatral, Gujarat, India |
| Trexgen Pharmaceuticals Private Limited | ₹5.78 Cr (FY 2024) | 10.0% | Ahmedabad, Gujarat, India | |||
| Precia Pharma Private Limited | ₹5.77 Cr (FY 2023) | -53.0% | Thane, Maharashtra, India |
To see the full peer comparison of Nucleus Formulation Private Limited, buy the company report.
Auditor
Nucleus Formulation Private Limited is audited by BONY SHAH & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BONY SHAH & CO. | FY 2024 | 131458W |
Shareholding
The shareholding of Nucleus Formulation Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nucleus Formulation Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.57 Cr
Satisfied charges
₹5.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jul 2023 | 100755911 | Sidbi | ₹52.6 Lakh | Open | |
| 06 Jun 2023 | 100746083 | Others | ₹2 Cr | Open | |
| 24 Jun 2021 | 100465568 | Hdfc Bank Limited | ₹4 Lakh | Open | |
| 11 Apr 2019 | 100259131 | Others | ₹2.5 Cr | Satisfied | |
| 09 Oct 2014 | 10523872 | Hdfc Bank Limited | ₹1.36 Cr | Satisfied |
To see the full charge records of Nucleus Formulation Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Nucleus Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nucleus Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nucleus Formulation Private Limited has a workforce of 13 employees on its EPFO records as of Mar 06, 2025, across 1 active EPFO establishment.
Employee count
13
Active EPFO establishments
1
Employee growth
-7.14%
GST
Nucleus Formulation has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCN0507H1ZY | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nucleus Formulation Private Limited, buy the company report.
Recent activity
Nucleus Formulation Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Jayesh Sharadchandra Pandya ceased to be Director on 20 Mar 2021.
AGM
Nucleus Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nucleus Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Sidbi amounted to Rs. 52.60 Lakh with Charge ID 100755911 was registered on 28 Jul 2023.
Charges
A charge registered on 11 Apr 2019 via Charge ID 100259131 with Others was fully satisfied on 30 Jun 2023.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100746083 was registered on 06 Jun 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.00 Lakh with Charge ID 100465568 was registered on 24 Jun 2021.
Ceased
Jayesh Sharadchandra Pandya ceased to be Director.
Charges
A charge with Others of Rs. 250.00 Lakh registered on 11 Apr 2019 with Charge ID 100259131 was modified on 01 Jun 2019.
Charges
A charge registered on 09 Oct 2014 via Charge ID 10523872 with Hdfc Bank Limited was fully satisfied on 22 May 2019.
Charges
A charge with Others amounted to Rs. 250.00 Lakh with Charge ID 100259131 was registered on 11 Apr 2019.
Charges
A charge with Hdfc Bank Limited of Rs. 136.00 Lakh registered on 09 Oct 2014 with Charge ID 10523872 was modified on 10 Oct 2017.
Ceased
Sureshbhai Kadavabhai Patel ceased to be Director.
6 earlier events are in the company report.
Frequently asked questions
Nucleus Formulation is an active private limited company based in Chhatral, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 July 2009 (17+ years old) and is registered under CIN U24239GJ2009PTC057517.
Nucleus Formulation has 2 current directors:
- Jitendra Lavjibhai Patel - Director
- Dipesh Jyotindrakumar Thakar - Director
The latest financial statements of Nucleus Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nucleus Formulation is 24AADCN0507H1ZY, registered in Gujarat.
The CIN (Corporate Identification Number) of Nucleus Formulation is U24239GJ2009PTC057517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nucleus Formulation was incorporated on 13 July 2009, making it 17+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Nucleus Formulation by revenue are Aaryveda Global Healthcare (I) Private Limited, Trexgen Pharmaceuticals Private Limited, Precia Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jayesh Sharadchandra Pandya ceased to be Director on 20 Mar 2021. Sureshbhai Kadavabhai Patel ceased to be Director on 07 Oct 2015. Dipesh Jyotindrakumar Thakar was appointed as Director on 13 Jul 2009. Nucleus Formulation has 4 board changes on record in total.
Yes, Nucleus Formulation is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-09-0016842).
Nucleus Formulation can be reached through the website nucleusformulation.com. Its registered office is in Chhatral, Gujarat, India.
The registered office of Nucleus Formulation is at Plot No 3484 Ph – 4 GIDC Chhatral Tal Kalol, Gujarat, India – 382729.